CEDARS SINAI MEDICAL CENTER enters PROMETHEUS BIOSCIENCES, INC. with 592.50K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 592.50K | Direct |
| Total | 592.50K | 592.50K direct |
Series D-1 Preferred Stock
DirectUnderlying shares
254.44K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series A Preferred Stock
DirectUnderlying shares
100K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series B Preferred Stock
DirectUnderlying shares
1.20M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series C Preferred Stock
DirectUnderlying shares
2.50M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series D-2 Preferred Stock
DirectUnderlying shares
361.56K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Underlying
4.42M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series D-1 Preferred Stock Direct | Common Stock | — | — | 254.44K | N/A | |
| Series A Preferred Stock Direct | Common Stock | — | — | 100K | N/A | |
| Series B Preferred Stock Direct | Common Stock | — | — | 1.20M | N/A | |
| Series C Preferred Stock Direct | Common Stock | — | — | 2.50M | N/A | |
| Series D-2 Preferred Stock Direct | Common Stock | — | — | 361.56K | N/A | |
| Total | 4.42M | 0.00 | ||||